Cardiac hemangioma in children: case report
Erica V Stelmaszewski1, Mariel L Foti1, Carlos F Rosental1
1Department of Cardiology. Hospital J.P Garrahan. Buenos Aires, Argentina.
Cardiology in the Young
|July 3, 2025
Summary
A preterm infant with hepatic hemangiomas also developed cardiac hemangiomas and pericardial effusion. Treatment with propranolol led to the regression of both hepatic and cardiac hemangiomas over three years.
Area of Science:
- Pediatric Cardiology
- Neonatology
- Hepatology
Background:
- Hepatic hemangiomas are common benign liver tumors in neonates.
- Cardiac hemangiomas are rare and can lead to significant complications.
- Coexistence of hepatic and cardiac hemangiomas is exceptionally rare.
Purpose of the Study:
- To report a rare case of coexisting hepatic and cardiac hemangiomas in a preterm neonate.
- To describe the diagnostic and management approach.
- To highlight the importance of multidisciplinary care and long-term surveillance.
Main Methods:
- Diagnosis via routine screening, echocardiography, and ultrasound.
- Management included pericardiocentesis and propranolol therapy.
- Long-term follow-up over three years.
Main Results:
- A preterm neonate (36 weeks) presented with hepatic hemangiomas.
- Cardiac hemangiomas and pericardial effusion were identified, requiring intervention.
- Propranolol treatment resulted in complete regression of both hepatic and cardiac hemangiomas within three years without complications.
Conclusions:
- The coexistence of hepatic and cardiac hemangiomas is a rare clinical presentation.
- Multidisciplinary management involving neonatology, cardiology, and hepatology is crucial.
- Propranolol appears effective for treating both hepatic and cardiac hemangiomas, necessitating long-term follow-up.


